Compare Wockhardt with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs SANOFI INDIA - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT SANOFI INDIA WOCKHARDT/
SANOFI INDIA
 
P/E (TTM) x -23.0 35.1 - View Chart
P/BV x 1.2 6.2 19.7% View Chart
Dividend Yield % 0.0 1.4 0.2%  

Financials

 WOCKHARDT   SANOFI INDIA
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
SANOFI INDIA
Dec-18
WOCKHARDT/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0126,840 14.8%   
Low Rs5324,630 11.5%   
Sales per share (Unadj.) Rs355.91,203.1 29.6%  
Earnings per share (Unadj.) Rs-60.3165.3 -36.5%  
Cash flow per share (Unadj.) Rs-46.8209.9 -22.3%  
Dividends per share (Unadj.) Rs0.0184.00 0.0%  
Dividend yield (eoy) %01.5 0.1%  
Book value per share (Unadj.) Rs257.8963.6 26.8%  
Shares outstanding (eoy) m110.6323.03 480.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.8 45.5%   
Avg P/E ratio x-12.834.7 -36.9%  
P/CF ratio (eoy) x-16.527.3 -60.4%  
Price / Book Value ratio x3.06.0 50.3%  
Dividend payout %050.8 -0.0%   
Avg Mkt Cap Rs m85,379132,078 64.6%   
No. of employees `0006.33.3 189.5%   
Total wages/salary Rs m9,3714,068 230.3%   
Avg. sales/employee Rs Th6,295.08,393.8 75.0%   
Avg. wages/employee Rs Th1,498.31,232.4 121.6%   
Avg. net profit/employee Rs Th-1,066.31,153.0 -92.5%   
INCOME DATA
Net Sales Rs m39,36927,708 142.1%  
Other income Rs m1,202897 134.0%   
Total revenues Rs m40,57128,605 141.8%   
Gross profit Rs m186,235 0.3%  
Depreciation Rs m1,4951,027 145.6%   
Interest Rs m2,5557 36,498.6%   
Profit before tax Rs m-2,8306,098 -46.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2572,292 11.2%   
Profit after tax Rs m-6,6693,806 -175.2%  
Gross profit margin %022.5 0.2%  
Effective tax rate %-9.137.6 -24.2%   
Net profit margin %-16.913.7 -123.3%  
BALANCE SHEET DATA
Current assets Rs m33,79615,922 212.3%   
Current liabilities Rs m26,9176,235 431.7%   
Net working cap to sales %17.535.0 50.0%  
Current ratio x1.32.6 49.2%  
Inventory Days Days7964 124.7%  
Debtors Days Days8921 427.6%  
Net fixed assets Rs m39,6647,539 526.1%   
Share capital Rs m553230 240.5%   
"Free" reserves Rs m27,96821,962 127.3%   
Net worth Rs m28,52222,192 128.5%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62029,839 273.5%  
Interest coverage x-0.1872.1 -0.0%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.50.9 51.9%   
Return on assets %-5.012.8 -39.4%  
Return on equity %-23.417.2 -136.3%  
Return on capital %-7.727.5 -27.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8077,587 129.3%   
Fx outflow Rs m1,7897,145 25.0%   
Net fx Rs m8,019442 1,814.1%   
CASH FLOW
From Operations Rs m6843,739 18.3%  
From Investments Rs m6,302-731 -862.2%  
From Financial Activity Rs m-7,695-1,972 390.2%  
Net Cashflow Rs m-6641,036 -64.1%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 2.3 14.4 16.0%  
FIIs % 7.7 14.6 52.7%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 10.5 146.7%  
Shareholders   67,757 15,184 446.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  AUROBINDO PHARMA  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

The Week That Was: Of Macro Events and Auto Sector Blues(Podcast)

In yet again holiday shortened week, stock market sentiments were swayed by the macro events such as release of index of industrial production and consumer price index data.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Sep 13, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS